More durable and versatile therapeutic wearable material, more accurate part measurement and improved automation and 3D printing were among the many technologies on display at this year’s Medical Design & Manufacturing (MD&M) East conference, June 12-14, in New York City.
Displaying 1-10 of 45 results for
Alex Berry and his team at Sutrue Ltd. (Colchester, England) exploited the benefits of 3D printing prototypes when developing two new automated suturing devices. They also coined a phrase to describe their prototyping technique.
Some in the medical industry are using silicone rubber molds made with a 3D-printed master pattern for low-to-mid production runs of cast polyurethane device housings.
Contract manufacturers, aka job shops, are the heart and soul of US manufacturing. Their survival and success are imperative.
Digitization of industry has become an established global trend. Despite all the enthusiasm of visionaries, the machine tool is, was and will remain the core element in production.
An executive makes the case for why manufacturers may want to change how they procure health plans.
It’s not often you get the opportunity to witness rapid, life-impacting change, but for those of us who have been in the 3D printing industry over the last few decades, we have witnessed just that. In the last 20-plus years, 3D printing has changed the definition of manufacturing from merely “one-size-fits-all” to “customized” production and from “high-volume” to “high-complexity/low-volume”—a startling paradigm shift that has enabled many new applications for the manufacturing industry.
The Copper Development Association (CDA) is eager to help shops discover and tap into the high-speed machining advantages of brass. The substantial benefits of doing so have an increasing number of shops rethinking their part materials and, when possible, converting those parts to brass.
Living with the day-to-day reality of COVID-19 can be challenging for individuals. Running a business in this pandemic era is an order of magnitude harder.
Additive manufacturing (AM) in medicine continues to grow each year. It is a remarkable enabler, but the industry is fraught with barriers to adoption, slow for the sake of patient safety.